Dr. Vince Clinical Research Hires Two Industry Veterans, Bringing Over 50 Years’ Combined Research Experience

OVERLAND PARK, Kan.; July 26, 2022 (Business Wire) – Dr. Vince Clinical Research (DVCR), a world-class contract research organization (CRO) specializing in early phase clinical trials, today announced the addition of two key leadership roles to its Phase I research team.

Michelle Neaderhiser joins the organization as the Director of Study Management, leveraging her 25+ years of experience in clinical research. She will oversee the study management team at DVCR’s clinical pharmacology unit to ensure trials are completed per protocol and to the sponsor’s expectations.

“I am excited to join the Dr. Vince Clinical Research team and utilize my expertise in the execution of clinical studies by delivering data quality above industry standards,” Neaderhiser said.

Chris Hardage also joins DVCR with 25+ years of clinical research experience as the Director of Clinical Trial Services.

“I look forward to collaborating with my fellow colleagues on the leadership team as we develop solution-focused methods that result in the delivery of smarter, faster data®,” Hardage said.

“With these additions we have positioned ourselves as one of the most experienced early phase clinical research companies in the country, allowing us to provide smarter, faster data® to our biopharmaceutical clients,” said CEO and Medical Director Dr. Brad Vince. “Our organization continues to make significant investments in our employees and leadership team.”

About Dr. Vince Clinical Research

Dr. Vince Clinical Research (DVCR) is a full-service contract research organization (CRO) specializing in early phase trials in both healthy normal volunteers and patient populations across a wide range of trial designs and therapeutic areas such as neuroscience, substance abuse, pain, cardiometabolic disorders, infectious diseases and many others. CRO services include project management, data management, biostatistics, statistical programming, PK/PD analysis, medical writing, monitoring as well as site feasibility and management for multi-site trials. Additionally, DVCR operates one of the most innovative and technologically advanced clinical pharmacology units in the world with over 90 beds for overnight confinement, a cGMP compliant pharmacy as well as luxurious amenities to support diverse study participant recruitment and retention. By leveraging technology and one of the country’s most experienced leadership teams in early clinical development, DVCR provides Smarter Faster Data® to their biopharmaceutical clients.

For more information, go to sponsors.drvince.com. Connect with Dr. Vince Clinical Research on LinkedIn and YouTube. 

DVCR Contact:

Zach Bader

Vice President, Business Development

(913) 333-3000

Dr. Vince Clinical Research